Crispr Therapeutics AG (CRSPN) Q4 2021 Earnings Report

1 Followers

MX:CRSPN Q4 2021 EPS Results

Actual EPS: -MXN 34.66
Consensus EPS: -MXN 33.23
Beat/Miss: Missed by -MXN 1.43
One Year Ago EPS: -MXN 28.26

MX:CRSPN Q4 2021 Revenue Results

Actual Revenue: MXN 242.98M
Expected Revenue: MXN 41.16M
Beat/Miss: Beat by +MXN 201.82M
YoY Revenue Growth: +3386.22%

Earnings Announcement Details

Quarter: Q4 2021
Date: 02/15/2022
Time: TBA
Conference Call: Tuesday, February 15, 2022

MX:CRSPN Upcoming Earnings

Crispr Therapeutics AG's next earnings date is estimated for February 16, 2027, based on past reporting schedules.

Q4 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:CRSPN Earnings History

MX:CRSPN earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Feb 16, 2027	2026 (Q4)	-22.12-	-25.81	―	―
Nov 02, 2026	2026 (Q3)	-19.53-21.66	-22.04	1.71% (+0.38)
Aug 03, 2026	2026 (Q2)	-22.51-17.71	-45.21	60.83% (+27.50)
May 04, 2026	2026 (Q1)	-22.94-24.11	-29.76	18.99% (+5.65)
Feb 12, 2026	2025 (Q4)	-21.91-25.81	-8.29	-211.36% (-17.52)
Nov 10, 2025	2025 (Q3)	-23.83-22.04	-19.03	-15.84% (-3.01)
Aug 04, 2025	2025 (Q2)	-26.41-45.21	-28.07	-61.07% (-17.14)
May 06, 2025	2025 (Q1)	-23.43-29.76	-26.94	-10.49% (-2.83)
Feb 11, 2025	2024 (Q4)	-22.62-8.29	20.72	-140.00% (-29.01)
Nov 05, 2024	2024 (Q3)	-26.52-19.03	-26.56	28.37% (+7.53)
Aug 05, 2024	2024 (Q2)	-26.88-28.07	-18.46	-52.04% (-9.61)
May 08, 2024	2024 (Q1)	-25.64-26.94	-12.62	-113.43% (-14.32)
Feb 21, 2024	2023 (Q4)	1.2420.72	-26.56	178.01% (+47.28)
Nov 06, 2023	2023 (Q3)	-37.47-26.56	-42.2	37.05% (+15.64)
Aug 07, 2023	2023 (Q2)	-40.07-18.46	-45.21	59.17% (+26.75)
May 08, 2023	2023 (Q1)	-32.80-12.62	-43.7	71.12% (+31.08)
Feb 21, 2023	2022 (Q4)	-42.38-26.56	-34.66	23.37% (+8.10)
Nov 01, 2022	2022 (Q3)	-42.91-42.20	-31.46	-34.13% (-10.74)
Aug 08, 2022	2022 (Q2)	-41.76-45.21	177.82	-125.42% (-223.03)
May 09, 2022	2022 (Q1)	-36.53-43.70	-28.44	-53.64% (-15.26)
Feb 15, 2022	2021 (Q4)	-33.23-34.66	-28.26	-22.67% (-6.40)
Nov 03, 2021	2021 (Q3)	-33.02-31.46	-24.87	-26.52% (-6.59)
Jul 29, 2021	2021 (Q2)	66.35177.82	-24.49	826.15% (+202.31)
Apr 27, 2021	2021 (Q1)	―-28.44	-21.66	-31.30% (-6.78)
Feb 16, 2021	2020 (Q4)	―-28.26	9.61	-394.12% (-37.86)
Oct 28, 2020	2020 (Q3)	―-24.87	45.21	-155.00% (-70.07)
Jul 27, 2020	2020 (Q2)	―-24.49	-19.03	-28.71% (-5.46)
Apr 28, 2020	2020 (Q1)	―-21.66	-17.52	-23.66% (-4.14)
Feb 12, 2020	2019 (Q4)	―9.61	-17.33	155.43% (+26.94)
Oct 28, 2019	2019 (Q3)	―45.21	-20.16	324.30% (+65.37)
Jul 29, 2019	2019 (Q2)	―-19.03	-15.45	-23.17% (-3.58)
Apr 29, 2019	2019 (Q1)	―-17.52	-11.68	-50.00% (-5.84)
Feb 25, 2019	2018 (Q4)	―-17.33	0.06	-30766.67% (-17.39)
Nov 07, 2018	2018 (Q3)	―-20.16	-11.68	-72.58% (-8.48)
Aug 07, 2018	2018 (Q2)	―-15.45	-10.55	-46.43% (-4.90)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Crispr Therapeutics AG earnings date